Patent · US Active

Process for the preparation of a PDE4 inhibitor

US10759761B2 · kind B2 · utility

2Cited by
9References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2019
Grant dateSep 1, 2020
Priority date
Expiry dateApr 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.